Oscar Health reported $167.3 million in profit for third-quarter 2026, compared to a net loss of $137.5 million in the same period last year.
The company reported its third-quarter earnings Nov. 5. Oscar brought in $5.1 billion in revenue, a 72% year-over-year increase. That includes a $250 million benefit from updated risk adjustment estimates.
Earnings from operations reached $178 million, up from a $129.3 million loss in the third quarter of 2025.
The company’s medical loss ratio fell from 88.5% in third-quarter 2025 to 84%.
Oscar’s membership grew about 27% year over year, nearing 2.7 million effectuated members as of Sept. 30.
Oscar boosted its full-year outlook, expecting total revenue to range from $19 billion to $19.3 billion. The company anticipates earnings from operations to range from $850 million to $950 million.
“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time,” Oscar Health CEO Mark Bertolini said in a news release. “The ACA is the foundation of a rapidly-developing individual market in America, and Oscar Health is built to lead it. Our disciplined pricing, consumer-led products and technology-powered approach are driving stronger economics and position us to grow market share and expand margin in 2027.”
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
